Abstract: Systems, methods, and related technologies for entity classification are described. Entity attributes for entity classification are determined and entities coupled to a network are monitored. Values for each entity attribute for each entity coupled to the network are identified. A semantic similarity, between the plurality of entities, of the values for each entity attribute is determined. The entities are clustered into multiple entity clusters based on the semantic similarity of the values for each of the entity attributes for the entities.

Abstract: The present application relates to a method for desensitization of allergic patients. More specifically it relates to an epicutaneous desensitization method, applicable to any type of allergens and of patients. The method of the invention is essentially non-invasive and does not require the use of adjuvants. Further, it may be easily applied and monitored by the actual patient.

Abstract: Systems, methods, and related technologies for classification are described. Entity attribute data associated with network entities is obtained. One or more entity attributes for classifying a set of entities is determined based on the entity attribute data. A set of entities coupled to a network are monitored. Values of the one or more entity attributes for the plurality of entities is identified. The set of entities are clustered into one or more entity clusters based on a similarity of the one or more entity attributes for the entities. An entity fingerprinting action is then performed based on the entity clusters.

Abstract: The present application relates to a method for desensitization of allergic patients. More specifically it relates to an epicutaneous desensitization method, applicable to any type of allergens and of patients. The method of the invention is essentially non-invasive and does not require the use of adjuvants. Further, it may be easily applied and monitored by the actual patient.

Abstract: A multi-chain and multi-DEX decentralized finance (DeFi) portfolio tracker uses a powerful relational database with an improved, continuous, self-updating process that constantly reflects value changes and associations with respect to individual symbols (tokens) across varying blockchain networks by integrating smart contracts from individual DeFi protocols. A web-based platform, backed by the system, provides crypto traders and investors with a “hub” where they can more efficiently track and visualize their LP Token and Yield Farm asset performance.

Abstract: Systems, methods, and related technologies for classification are described. Entity attribute data associated with network entities is obtained. One or more entity attributes for classifying a set of entities is determined based on the entity attribute data. A set of entities coupled to a network are monitored. Values of the one or more entity attributes for the plurality of entities is identified. The set of entities are clustered into one or more entity clusters based on a similarity of the one or more entity attributes for the entities. An entity fingerprinting action is then performed based on the entity clusters.

Abstract: The present application relates to a method for desensitization of allergic patients. More specifically it relates to an epicutaneous desensitization method, applicable to any type of allergens and of patients. The method of the invention is essentially non-invasive and does not require the use of adjuvants. Further, it may be easily applied and monitored by the actual patient.

Abstract: The present application relates to a method for desensitization of allergic patients. More specifically it relates to an epicutaneous desensitization method, applicable to any type of allergens and of patients. The method of the invention is essentially non-invasive and does not require the use of adjuvants. Further, it may be easily applied and monitored by the actual patient.

Abstract: The invention relates to novel compositions and methods for diagnosing or treating food allergies. The invention particularly discloses new approaches for delivering food allergens to allergic patients by oral administration of formulations which dissolve and release proteins in the stomach. The invention allows the treatment of food allergies by delivering food allergens to the gut immune system with controlled exposure of the esophagus or oral cavity. The invention also allows to perform food challenges to assess the threshold of clinical reactivity without exposing the esophagus and oral cavity. The invention may be used in any subject, particularly human subjects, and is applicable to any food allergen.

Abstract: The present application relates to a method for desensitization of allergic patients. More specifically it relates to an epicutaneous desensitization method, applicable to any type of allergens and of patients. The method of the invention is essentially non-invasive and does not require the use of adjuvants. Further, it may be easily applied and monitored by the actual patient.

Abstract: The present application relates to a method for desensitization of allergic patients. More specifically it relates to an epicutaneous desensitization method, applicable to any type of allergens and of patients. The method of the invention is essentially non-invasive and does not require the use of adjuvants. Further, it may be easily applied and monitored by the actual patient.

Abstract: The present application relates to a method for desensitization of allergic patients. More specifically it relates to an epicutaneous desensitization method, applicable to any type of allergens and of patients. The method of the invention is essentially non-invasive and does not require the use of adjuvants. Further, it may be easily applied and monitored by the actual patient.

Abstract: The invention relates to novel compositions and methods for diagnosing or treating food allergies. The invention particularly discloses new approaches for delivering food allergens to allergic patients by oral administration of formulations which dissolve and release proteins in the stomach. The invention allows the treatment of food allergies by delivering food allergens to the gut immune system with controlled exposure of the esophagus or oral cavity. The invention also allows to perform food challenges to assess the threshold of clinical reactivity without exposing the esophagus and oral cavity. The invention may be used in any subject, particularly human subjects, and is applicable to any food allergen.

Abstract: The present application relates to a method for desensitization of allergic patients. More specifically it relates to an epicutaneous desensitization method, applicable to any type of allergens and of patients. The method of the invention is essentially non-invasive and does not require the use of adjuvants. Further, it may be easily applied and monitored by the actual patient.

Abstract: The present application relates to a method for desensitization of allergic patients. More specifically it relates to an epicutaneous desensitization method, applicable to any type of allergens and of patients. The method of the invention is essentially non-invasive and does not require the use of adjuvants. Further, it may be easily applied and monitored by the actual patient.

Abstract: The present application relates to a method for desensitization of allergic patients. More specifically it relates to an epicutaneous desensitization method, applicable to any type of allergens and of patients. The method of the invention is essentially non-invasive and does not require the use of adjuvants. Further, it may be easily applied and monitored by the actual patient.

Abstract: The present application relates to a method for desensitization of allergic patients. More specifically it relates to an epicutaneous desensitization method, applicable to any type of allergens and of patients. The method of the invention is essentially non-invasive and does not require the use of adjuvants. Further, it may be easily applied and monitored by the actual patient.

Abstract: The invention relates to a composition consisting of a mixture of one or more metal oxides having the formula MxOyUi, in which M is a metal atom selected from among iron, aluminum, titanium, manganese, zinc, copper, zirconium, nickel, and lead, O is an oxygen atom, U is an impurity, and x, y, and i are mole fractions comprised between 0 and 1, with x+y>80%, said composition taking the form of a three-dimensional compacted tablet having an apparent density greater than or equal to 2, an apparent porosity comprised between 3% and 40%, and a diametral breaking strength greater than or equal to 250 kPa.

Abstract: The present application relates to a method for desensitization of allergic patients. More specifically it relates to an epicutaneous desensitization method, applicable to any type of allergens and of patients. The method of the invention is essentially non-invasive and does not require the use of adjuvants. Further, it may be easily applied and monitored by the actual patient.

Abstract: The present invention relates to compositions and methods for preventing allergy in a subject. Particularly, the present invention relates to epicutaneous prevention of allergies in children. The invention also relates to compositions for use in such methods, as well as their manufacture. The invention may be used to cause protection against any allergy, particularly food or respiratory allergies.